Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors

Conclusion The study confirms differences in CV risk factors between different cART drugs and this should be considered during initiation of the therapy.
Source: HIV and AIDS Review - Category: Infectious Diseases Source Type: research